Main menu

Accelerating cancer research through comprehensive genomic analysis


White paper: cancer research — 2 pages

Overview

Cancer is a challenging multifactorial disease and the rapid advancement of sequencing technologies over the last two decades has revealed unprecedented insights into the genomic causes and implications of cancer. However, a vast proportion of cancers cannot be explained by simple point mutations detected using legacy short-read sequencing technologies.

In this white paper, discover how Oxford Nanopore sequencing technology provides extensive analyses of structural variants, repeat regions, DNA/RNA methylation, cell-free and circulating tumour DNA (cfDNA and ctDNA), fusion genes and full-length transcript isoforms to truly understand cancer biology.

In this white paper, you will:

  • Learn the importance of cancer research and its recent developments
  • Discover the limitations of legacy sequencing technologies
  • Find out how Oxford Nanopore sequencing overcomes these limitations
  • Read real-world case studies of how researchers are utilising Oxford Nanopore sequencing to deliver new insights into a wide range of cancers, including retinoblastoma, acute pediatric leukaemia, and hereditary cancer

Download

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag